Recent Posts
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
- Cycle Pharmaceuticals Secures $25 Million Debt Financing
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
Archives
-
-
Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of DirectorsSeptember 8th, 2020 -
Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020September 8th, 2020
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
- Cycle Pharmaceuticals Secures $25 Million Debt Financing
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
Recent Tweets
-
Avada + WooCommerce is the fastest way to get your business online to start selling. Flexible, highly customizable,… twitter.com/i/web/status/1…
3 days ago -
Build the forms you want. Coming soon! #avada #WordPress #LeadGeneration pic.twitter.com/SE4YfYDevm
1 week ago -
Building a new online presence or growing an existing site? Use of the available resources to get the most out of t… twitter.com/i/web/status/1…
2 weeks ago
Recent Comments